Prime Medicine, Inc (PRME) Price Prediction & ForecastPRMEPrime Medicine, Inc

Alphio's PRME stock price prediction model matches the current Prime Medicine, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.48 (-2.66%). The 1-week path is $3.49 (-2.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Prime Medicine Inc is a good buy right now due to its recent 6.49% increase over the last 5 days and a favorable RSI of 61.217, indicating bullish momentum. The positive arbitration ruling against Beam Therapeutics has removed a significant overhang, allowing the company to advance its PM647 treatment, which is expected to enter clinical trials soon. However, the main risk is the company's ongoing net losses, with a net income of -42,109,000 USD in Q2 2026, which highlights the financial challenges it faces as it seeks to commercialize its technology.

Prime Medicine, Inc (PRME) last closed at $3.57, losing -0.56%. These facts feed the 1-day and 1-week PRME price prediction above.